BIOMAT Database Logo BIOMAT Database Logo

Monthly intravenous pulse cyclophosphamide therapy in Wegener's granulomatosis. 1996

D Lê Thi Huong, and T Papo, and J C Piette, and B Wechsler, and O Blétry, and G Lamas, and A Baumelou, and P Le Hoang, and J L Pennaforte, and J C Valcke, and P Godeau
Department of Internal Medicine, Groupe Hospitalier Pitié-Salpétrière, Paris, France.

OBJECTIVE To study the long term effects of monthly intravenous cyclophosphamide therapy in Wegener's granulomatosis. METHODS Fourteen consecutive patients with active Wegener's granulomatos treated with a first-line combination of high-dose prednisone and monthly intravenous pulse cyclophosphamide were retrospectively studied. RESULTS One patient died from septicemia complicating severe leukopenia after the first pulse. At 8 months after instituting intravenous pulse cyclophosphamide therapy, failure was observed in 6 other patients. Between month 16 and 18, 2 other patients relapsed when the time between 2 pulses was lengthened. Five patients developed cyclophosphamide-related side-effects: infection (n = 2), amenorrhea (n = 1), alopecia (n = 2) and vomiting (n = 2). Except for one fatal infection, no major side-effect of intravenous cyclophosphamide therapy was observed. At the end of the study, all patients were off intravenous cyclophosphamide therapy with more than 6 months of followup. The 6 responders were in remission on low-dose prednisone or without treatment. CONCLUSIONS A combination of high-dose prednisone and intravenous cyclophosphamide may achieve long-term remission in 42% of patients with Wegener's granulomatosis. Responders to intravenous cyclophosphamide therapy had less extensive disease than non-responders.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females

Related Publications

D Lê Thi Huong, and T Papo, and J C Piette, and B Wechsler, and O Blétry, and G Lamas, and A Baumelou, and P Le Hoang, and J L Pennaforte, and J C Valcke, and P Godeau
Cyclophosphamide pulse therapy in Wegener's granulomatosis.
January 1991, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
D Lê Thi Huong, and T Papo, and J C Piette, and B Wechsler, and O Blétry, and G Lamas, and A Baumelou, and P Le Hoang, and J L Pennaforte, and J C Valcke, and P Godeau
Pulse cyclophosphamide therapy for Wegener's granulomatosis.
September 1991, The American journal of medicine,
D Lê Thi Huong, and T Papo, and J C Piette, and B Wechsler, and O Blétry, and G Lamas, and A Baumelou, and P Le Hoang, and J L Pennaforte, and J C Valcke, and P Godeau
Pulse cyclophosphamide therapy in Wegener's granulomatosis: a pilot study.
September 1992, Journal of internal medicine,
D Lê Thi Huong, and T Papo, and J C Piette, and B Wechsler, and O Blétry, and G Lamas, and A Baumelou, and P Le Hoang, and J L Pennaforte, and J C Valcke, and P Godeau
Immunosuppressive therapy with cyclophosphamide pulse doses in Wegener's granulomatosis.
May 2001, Transplantation proceedings,
D Lê Thi Huong, and T Papo, and J C Piette, and B Wechsler, and O Blétry, and G Lamas, and A Baumelou, and P Le Hoang, and J L Pennaforte, and J C Valcke, and P Godeau
Successful treatment with intravenous cyclophosphamide pulse therapy of severe intestinal involvement in Wegener's granulomatosis.
January 2006, Scandinavian journal of rheumatology,
D Lê Thi Huong, and T Papo, and J C Piette, and B Wechsler, and O Blétry, and G Lamas, and A Baumelou, and P Le Hoang, and J L Pennaforte, and J C Valcke, and P Godeau
Respiratory failure in Wegener's granulomatosis: response to pulse intravenous methylprednisolone and cyclophosphamide.
March 1993, The Journal of rheumatology,
D Lê Thi Huong, and T Papo, and J C Piette, and B Wechsler, and O Blétry, and G Lamas, and A Baumelou, and P Le Hoang, and J L Pennaforte, and J C Valcke, and P Godeau
Cyclophosphamide therapy in Wegener's granulomatosis.
April 1971, The New England journal of medicine,
D Lê Thi Huong, and T Papo, and J C Piette, and B Wechsler, and O Blétry, and G Lamas, and A Baumelou, and P Le Hoang, and J L Pennaforte, and J C Valcke, and P Godeau
Effectiveness of cyclophosphamide pulse treatment in Wegener's granulomatosis.
January 1993, Advances in experimental medicine and biology,
D Lê Thi Huong, and T Papo, and J C Piette, and B Wechsler, and O Blétry, and G Lamas, and A Baumelou, and P Le Hoang, and J L Pennaforte, and J C Valcke, and P Godeau
Cardiomyopathy following intravenous cyclophosphamide therapy in a patient with Wegener's granulomatosis.
January 1996, Clinical and experimental rheumatology,
D Lê Thi Huong, and T Papo, and J C Piette, and B Wechsler, and O Blétry, and G Lamas, and A Baumelou, and P Le Hoang, and J L Pennaforte, and J C Valcke, and P Godeau
Ocular involvement in Wegener's granulomatosis responding to intravenous cyclophosphamide.
September 2001, Rheumatology (Oxford, England),
Copied contents to your clipboard!